Germline mutations in the TP53 gene are responsible for Li–Fraumeni syndrome, which is characterized by autosomal dominant inheritance and early onset of a wide range of tumor types, including soft tissue sarcomas and osteosarcomas, breast cancer, brain tumors, leukemia, and adrenocortical carcinoma. The gene discussed is TP53; the disease is breast cancer.